Spectral characterization, CT-DNA binding, DFT/B3LYP, molecular docking and antitumor studies for new nano-sized VO(II)-hydrazonoyl complexes

Fig. 1A. Structures for, hydrazonoyl ligands (HL1-5), (HOPH, HMPH, HMoPH, HCPH and HBPH).39